Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gray A., Fenn P. Alzheimer's disease: the burden of the illness in England. Health Trends. 1993;25(1):31–37. [PubMed] [Google Scholar]
- Gray S. Advertisements for donepezil (Aricept) in the BMJ. Advertisement suggests an unrealistic improvement in mental status. BMJ. 1997 May 24;314(7093):1555–1555. [PMC free article] [PubMed] [Google Scholar]
- Kelly C. A., Harvey R. J., Cayton H. Drug treatments for Alzheimer's disease. BMJ. 1997 Mar 8;314(7082):693–694. doi: 10.1136/bmj.314.7082.693. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Knopman D., Schneider L., Davis K., Talwalker S., Smith F., Hoover T., Gracon S. Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group. Neurology. 1996 Jul;47(1):166–177. doi: 10.1212/wnl.47.1.166. [DOI] [PubMed] [Google Scholar]
- Lubeck D. P., Mazonson P. D., Bowe T. Potential effect of tacrine on expenditures for Alzheimer's disease. Med Interface. 1994 Oct;7(10):130–138. [PubMed] [Google Scholar]
- Rogers S. L., Friedhoff L. T. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group. Dementia. 1996 Nov-Dec;7(6):293–303. doi: 10.1159/000106895. [DOI] [PubMed] [Google Scholar]
- Smith K., Shah A., Wright K., Lewis G. The prevalence and costs of psychiatric disorders and learning disabilities. Br J Psychiatry. 1995 Jan;166(1):9–18. doi: 10.1192/bjp.166.1.9. [DOI] [PubMed] [Google Scholar]
- Wagner N. Advertisements for donepezil (Aricept) in the BMJ. Local committee has declined to approve NHS hospital prescription of donepezil. BMJ. 1997 May 24;314(7093):1555–1556. [PMC free article] [PubMed] [Google Scholar]